Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121

Abdulle, Amaal Eman; van Goor, Harry; Mulder, Douwe J.

doi:10.3390/ijms20225663

Open AccessCorrection

Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121

by

Amaal Eman Abdulle

^1,*

,

Harry van Goor

^2,†

and

Douwe J. Mulder

^1,†

¹

Department of Internal Medicine, Division Vascular Medicine, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands

²

Department of Pathology and Medical Biology, Section Pathology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands

^*

Author to whom correspondence should be addressed.

^†

These authors contributed equally to this work.

Int. J. Mol. Sci. 2019, 20(22), 5663; https://doi.org/10.3390/ijms20225663

Submission received: 25 October 2019 / Accepted: 4 November 2019 / Published: 12 November 2019

(This article belongs to the Section Biochemistry)

Download Versions Notes

The authors wish to make the following correction to this paper [1].

Reference [8] refers to the wrong article. The correct reference [2] should be:

Abdulle, A.E.; Diercks, G.F.H.; Feelisch, M.; Mulder, D.J.; van Goor, H. The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy. Front. Physiol. 2018, 9, 1–15, doi:10.3389/fphys.2018.01177.

The authors would like to apologize for any inconvenience caused to the readers by these changes.

References

Abdulle, A.E.; van Goor, H.; Mulder, D.J. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121. [Google Scholar] [CrossRef] [PubMed]
Abdulle, A.E.; Diercks, G.F.H.; Feelisch, M.; Mulder, D.J.; van Goor, H. The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy. Front. Physiol. 2018, 9, 1–15. [Google Scholar] [CrossRef] [PubMed] [Green Version]

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Abdulle, A.E.; van Goor, H.; Mulder, D.J. Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121. Int. J. Mol. Sci. 2019, 20, 5663. https://doi.org/10.3390/ijms20225663

AMA Style

Abdulle AE, van Goor H, Mulder DJ. Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121. International Journal of Molecular Sciences. 2019; 20(22):5663. https://doi.org/10.3390/ijms20225663

Chicago/Turabian Style

Abdulle, Amaal Eman, Harry van Goor, and Douwe J. Mulder. 2019. "Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121" International Journal of Molecular Sciences 20, no. 22: 5663. https://doi.org/10.3390/ijms20225663

APA Style

Abdulle, A. E., van Goor, H., & Mulder, D. J. (2019). Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121. International Journal of Molecular Sciences, 20(22), 5663. https://doi.org/10.3390/ijms20225663

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121

References

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI